blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0897986

EP0897986 - Aspartic proteinase 5 (ASP5) [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.09.2002
Database last updated on 11.09.2024
Most recent event   Tooltip13.09.2002Application deemed to be withdrawnpublished on 30.10.2002  [2002/44]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza P.O. Box 7929
Philadelphia, PA 19101 / US
[N/P]
Former [1999/08]For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza, P.O. Box 7929
Philadelphia Pennsylvania 19101 / US
Inventor(s)01 / Powell, David J, SmithKline Beecham Pharm.
709 Swedeland Road
King of Prussia, Pennsylvania 19406 / US
02 / Smith, Trudi, SmithKline Beecham Pharmaceuticals
709 Swedeland Road
King of Prussia, Pennsylvania 19406 / US
03 / Kay, John, University of Cardiff-Wales
Wales / GB
04 / Hill, Jeffrey SmithKline Beecham Pharmaceuticals
New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
[1999/20]
Former [1999/08]01 / Powell, David J, SmithKline Beecham Pharm.
709 Swedeland Road
King of Prussia, Pennsylvania 19406 / US
02 / Smith, Trudi, SmithKline Beecham Pharmaceuticals
709 Swedeland Road
King of Prussia, Pennsylvania 19406 / US
03 / Kay, John, University of Cardiff-Wales
Wales / GB
04 / Hill, Jeffrey
University of Cardiff-Wales
Wales / GB
Representative(s)Crump, Julian Richard John, et al
Cleveland
40-43 Chancery Lane
London WC2A 1JQ / GB
[N/P]
Former [1999/08]Crump, Julian Richard John, et al
FJ Cleveland, 40-43 Chancery Lane
London WC2A 1JQ / GB
Application number, filing date98306444.513.08.1998
[1999/08]
Priority number, dateUS19970056480P21.08.1997         Original published format: US 56480 P
US1998011172708.07.1998         Original published format: US 111727
[1999/08]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0897986
Date:24.02.1999
Language:EN
[1999/08]
Type: A1 / A2 RE Reissue of A-publication
No.:EP0897986
Date:01.09.1999
[1999/35]
Type: A3 Search report 
No.:EP0897986
Date:05.07.2000
[2000/27]
Search report(s)(Supplementary) European search report - dispatched on:EP22.05.2000
ClassificationIPC:C12N15/57, C12N9/64, C07K16/40, A61K48/00, A61K31/70, A61K38/48, C12Q1/68, C12Q1/37, C12N1/21, C12N5/10
[1999/08]
CPC:
A61P11/00 (EP); A61P11/06 (EP); A61P9/12 (EP);
C12N9/6478 (EP); A61K38/00 (EP); A61K48/00 (EP)
Designated contracting statesBE,   CH,   DE,   DK,   FR,   GB,   IT,   LI,   NL [2001/11]
Former [1999/08]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Aspartat proteinase 5 (ASP5)[1999/08]
English:Aspartic proteinase 5 (ASP5)[1999/08]
French:Protéinase aspartique 5[1999/08]
Examination procedure05.01.2001Examination requested  [2001/10]
31.07.2001Despatch of a communication from the examining division (Time limit: M08)
11.04.2002Application deemed to be withdrawn, date of legal effect  [2002/44]
23.05.2002Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2002/44]
Fees paidRenewal fee
31.08.2000Renewal fee patent year 03
31.08.2001Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PDX]WO9811236  (SMITHKLINE BEECHAM PLC [GB], et al) [PDX] 1-6,8-14 * page 1, line 33 - page 2, line 8 * * page 3, line 7 - page 5, line 19 * * page 8, line 12 - page 13, line 5 * * page 14, line 32 - line 37 * * page 15, line 19 - page 17, line 16 *;
 [PX]WO9813484  (INCYTE PHARMA INC [US], et al) [PX] 1-6,8-14 * page 7, line 22 - line 27 * * page 8, line 2 - line 13 * * page 11, line 12 - page 28, line 20 * * page 32, line 25 - page 33, line 16 *;
 [PX]WO9822597  (OKLAHOMA MED RES FOUND [US]) [PX] 1-5,8-14 * page 4, line 20 - page 16, line 13; figure 4 *;
 [E]WO9936550  (INCYTE PHARMA INC [US], et al) [E] 1-6,8-14 * page 5, line 15 - page 8, line 22 * * page 20, line 21 - page 21, line 8 * * page 30, line 22 - page 55, line 9 * * sequence listing SEQ ID NO:4 and 16 *;
 [E]WO0004137  (INCYTE PHARMA INC [US], et al) [E] 1-6,8-14 * page 2, line 20 - page 4, line 35 * * page 20, line 16 - page 40, line 5 *
 [X]  - KIYOSHI MORI ET AL., "Molecular cloning of a novel mouse aspartic protease-like protein that is expressed abundantly in the kidney", FEBS LETTERS, AMSTERDAM NL, (19970120), vol. 401, pages 218 - 222, XP002052496 [X] 1-6,8-14 * page 219, column L, paragraph 3 - page 220, column L, paragraph 2; figure 1 *

DOI:   http://dx.doi.org/10.1016/S0014-5793(96)01473-1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.